Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial
June 30, 2025
Nicox SA, an international ophthalmology company, announced that the last patient has completed the Denali Phase 3 trial, evaluating the efficacy and safety of NCX